IONS Ionis Pharma: Sotuvning sof marjinal rentabelligi

ionispharma.com (IONS) - korporativ logo

Ionis Pharmaceuticals rahbariyati ilm-fanga kiritilgan investitsiyalar bilan qo'llab-quvvatlanadigan to'g'ridan-to'g'ri sotuvlarga o'tish orqali o'z strategiyasini o'zgartirmoqda. Kompaniyaning sof marja koeffitsiyenti ushbu yo'nalishning samaradorligini ko'rsatadi, bunda -56.90 darajasi parametrning holatini belgilaydi. Texnologiyalarni sanoat gigantlariga litsenziyalash taqsimot xarajatlarini yo'qotish orqali kuchli imkoniyatlar yaratadi, moliyaviy barqarorlik esa royalti to'lovlariga va yangi dori vositalari uchun o'tkazilayotgan klinik sinovlarning muvaffaqiyatiga bog'liq.

ionispharma.com (IONS) - Sof marja 04.07.2022dan 19.11.2026gacha

Ionis Pharma - tahliliy kesimlar va asosiy koʻrsatkichlar (IONS)

- aksiya kursi va ekspertlarning narx prognozi:
Kompaniyaning barcha koʻrsatkichlari tahlili:Ionis Pharmaceuticals, Inc. - IONS
Ionis Pharmaceuticals, Inc. tayyor mahsulotlari

Sof foyda marjasi barcha operatsion va moliyaviy xarajatlar chegirib tashlanganidan keyin tushumdan qolgan foyda qismini o'lchaydi va xarajatlarni boshqarish samaradorligini aniqlaydi. Yakuniy savdo marjasini tahlil qilish orqali investor Ionis Pharmaceuticals (IONS) kompaniyasining o'z ishlanmalaridan foyda olish qobiliyatini baholaydi, bu esa foydaning to'liq saqlanishini ta'minlash uchun litsenziyalashdan dori vositalarini mustaqil ravishda bozorga chiqarishga o'tish bilan isbotlanadi.

Asosiy raqobatchilar

TEM: Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha marjinallik Qiagen QGEN|Sof marja Repligen|Avidity (RNA) - Kompaniya sotuv marjasi|Sotuvning sof marjinal rentabelligi CRSP|Kompaniya sotuv marjasi GeneDx|Sof marja Ultragenyx RARE|Kompaniya sotuv marjasi Beam Therapeutics (BEAM)|SRPT: Sof foyda bo'yicha sotuv rentabelligi|Sof marja Twist Bioscience|TXG (10x Genomics) - Sof foyda bo'yicha sotuv rentabelligi|Intellia Therapeutics, Inc. (NTLA) - Sotuvning sof marjinal rentabelligi|Sof marja Stoke Therapeutics Inc|BLFS: Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi WVE (Wave Life Sciences Corp)|Kompaniya sotuv marjasi Maze Therapeutics Corp|Sionna Therapeutics Inc - Sof foyda bo'yicha sotuv rentabelligi|PRME (primemedicine.com) - Sof foyda marjasi|TSHA - Sof marja|QURE (uniQure) - Sotuvning sof rentabelligi|MeiraGTx Corp (MGTX) - Sof marja|Regenxbio - Sof foyda normasi|Sof marja solidbio.com|Sof marja ocugen.com OCGN|Sotuvning sof marjinal rentabelligi PACB|Benitec - Sotuvning sof rentabelligi|Sof marja Design Therapeutics DSGN|Sotuvning sof marjinal rentabelligi Rocket Pharmaceuticals RCKT|Sof foyda marjasi 4D Molecular Corp|LXEO: Sof marja|KRRO (Korro Bio, Inc) - Sof foyda bo'yicha sotuv rentabelligi|Editas Medicine (EDIT) - Sotuvning sof marjinal rentabelligi|Sof marja Silence Therapeutics Inc.|Sotuvning sof rentabelligi PRQR (proqr.com)|Sof marja Codexis Bio (CDXS)|Sotuvning sof marjinal rentabelligi sangamo.com (SGMO)|Sof marja nautilus.bio NAUT|Kompaniya sotuv marjasi Metagenomi, Inc (MGX)|Precision BioSciences Inc. - Sotuvning sof marjinal rentabelligi|GBIO - Sotuvning sof marjinal rentabelligi|BOLD: Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi XCUR|Sof marja Imunon|Phio Pharmaceuticals - Sof foyda marjasi|Sof marja Mustang Bio, Inc. (MBIO)|Kompaniya sotuv marjasi TransCode Therapeutics, Inc.|Sof marja Bionano Genomics BNGO|Sof foyda normasi APDN|BLUE - Sof marja|Sof foyda marjasi IPA|Omega Therapeutics, Inc. (OMGA) - Sof marja|Singular Genomics Corp (OMIC) - Sotuvning sof marjinal rentabelligi|RGLS (Regulus Therapeutics, Inc.) - Sotuvning sof marjinal rentabelligi|SYRS: Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi TBIO (Telesis Bio Inc.)|Sotuvning sof marjinal rentabelligi TRACON Pharmaceuticals Inc. (TCON)|Sof marja Unity Bio UBX